Qigong and Fibromyalgia circa 2017
Abstract
:1. Introduction
2. Clinical Evidence and Observations
3. Methodological and Interpretational Challenges of Qigong Trials
4. Summary and Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Chen, K.W. Methodological challenges and research design in research study of qigong therapies. In Methodologies for Effective Assessing Complementary and Alternative Medicine (CAM): Research Tools and Techniques; Langueiler, M.J., McCarthy, P.W., Eds.; Singing Dragon: Jessica Kingsley Publications, London, UK, 2015; pp. 228–248. [Google Scholar]
- Larkey, L.; Jahnke, R.; Gonzalez, J. Meditative movement as a category of exercise: Implications for research. J. Phys. Act. Health 2009, 6, 230–238. [Google Scholar] [CrossRef] [PubMed]
- Payne, P.; Crane-Godreau, M.A. Meditative movement for depression and anxiety. Front. Psychiatry 2013, 4. [Google Scholar] [CrossRef] [PubMed]
- Schmalzl, L.; Crane-Godreau, M.A.; Payne, P. Movement-based embodied contemplative practices: Definitions and paradigms. Front. Hum. Neurosci. 2014, 8. [Google Scholar] [CrossRef] [PubMed]
- McBeth, J.; Mulvey, M.R. Fibromyalgia: Mechanisms and potential impact of the ACR 2010 classification criteria. Nat. Rev. Rheumatol. 2012, 8, 108–116. [Google Scholar] [CrossRef] [PubMed]
- Wolfe, F.; Clauw, D.J.; Fitzcharles, M.A.; Goldenberg, D.L.; Häuser, W.; Katz, R.L.; Mease, P.J.; Russell, A.S.; Russell, I.J.; Walitt, B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 2016, 46, 319–329. [Google Scholar] [CrossRef] [PubMed]
- Yunus, M.B. Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of diseases versus illness. Semin. Arthritis Rheum. 2008, 37, 339–352. [Google Scholar] [CrossRef] [PubMed]
- Thieme, K.; Mathys, M.; Turk, D.C. Evidence-based guidelines on the treatment of fibromyalgia patients—Are they consistent and if not, why not? Have effective psychological treatments been overlooked? J. Pain 2016. [Google Scholar] [CrossRef] [PubMed]
- Lauche, R.; Cramer, H.; Häuser, W.; Dobos, G.; Langhorst, J. A systematic overview of reviews for complementary and alternative therapies in the treatment of the fibromyalgia syndrome. Evid. Based Complement. Altern. Med. 2015. [Google Scholar] [CrossRef] [PubMed]
- Bidonde, J.; Busch, A.J.; Bath, B.; Milosavljevic, S. Exercise for adults with fibromyalgia: An umbrella systematic review with synthesis of best evidence. Curr. Rheumatol. Rev. 2014, 10, 45–79. [Google Scholar] [CrossRef] [PubMed]
- Theadom, A.; Cropley, M.; Smith, H.E.; Feigin, V.L.; McPherson, K. Mind and body therapy for fibromyalgia. Cochrane Database Syst. Rev. 2015. [Google Scholar] [CrossRef]
- Langhorst, J.; Klose, P.; Dobos, G.J.; Berhardy, K.; Häuser, W. Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: A systematic review and meta-analysis of randomized controlled trials. Rheumatol. Int. 2013, 33, 193–207. [Google Scholar] [CrossRef] [PubMed]
- Lauche, R.; Cramer, H.; Häuser, W.; Dobos, G.; Langhorst, J. A systematic review and meta-analysis of qigong for the fibromyalgia syndrome. Evid. Based Complement. Altern. Med. 2013. [Google Scholar] [CrossRef] [PubMed]
- Mist, S.D.; Firestone, K.A.; Jones, K.D. Complementary and alternative exercise for fibromyalgia: A meta-analysis. J. Pain Res. 2013, 6, 247–260. [Google Scholar] [CrossRef] [PubMed]
- Sawynok, J.; Lynch, M. Qigong and fibromyalgia: Randomized controlled trials and beyond. Evid. Based Complement. Altern. Med. 2014, 2014. [Google Scholar] [CrossRef] [PubMed]
- Del Rosso, A.; Maddali-Bongi, S. Mind body therapies in rehabilitation of patients with rheumatic diseases. Complement. Ther. Clin. Pract. 2016, 22, 80–86. [Google Scholar] [CrossRef] [PubMed]
- Astin, J.A.; Berman, B.M.; Bausell, B.; Lee, W.L.; Hochberg, M.; Forys, K.L. The efficacy of mindfulness meditation plus qigong movement therapy in the treatment of fibromyalgia: A randomized controlled trial. J. Rheumatol. 2003, 30, 2257–2262. [Google Scholar] [PubMed]
- Mannerkorpi, K.; Arndorw, M. Efficacy and feasibility of a combination of body awareness therapy and qigong in patients with fibromyalgia: A pilot study. J. Rehabil. Med. 2004, 36, 279–281. [Google Scholar] [CrossRef] [PubMed]
- Haak, T.; Scott, B. The effect of qigong on fibromyalgia (FMS): A controlled randomized study. Dis. Rehabil. 2008, 30, 625–633. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Zahner, L.; Cornell, M.; Le, T.; Ratner, J.; Wang, Y.; Pasnor, M.; Dimachkie, M.; Barohn, R. Benefit of qigong exercise in patients with fibromyalgia: A pilot study. Int. J. Neurosci. 2012, 122, 657–664. [Google Scholar] [CrossRef] [PubMed]
- Lynch, M.; Sawynok, J.; Marcon, D. A randomized controlled trial of qigong for fibromyalgia. Arthritis Res. Ther. 2012, 14, R178. [Google Scholar] [CrossRef] [PubMed]
- Maddali Bongi, S.; Del Rosso, A.; Di Felice, C.; Calà, M.; Giambalvo Dal Ben, G. Rességuier method and qigong sequentially integrated in patients with fibromyalgia syndrome. Clin. Exp. Rheumatol. 2012, 30 (Suppl. 74), S51–S58. [Google Scholar]
- Chen, K.W.; Hassett, A.L.; Hou, F.; Staler, J.; Lichtbroun, A.S. A pilot study of external qigong therapy for patients with fibromyalgia. J. Altern. Complement. Med. 2006, 9, 851–856. [Google Scholar] [CrossRef] [PubMed]
- Stephens, S.; Feldman, B.M.N.; Bradley, N.; Schneiderman, J.; Wright, V.; Singh-Grewal, D.; Lefebvre, A.; Benseler, S.M.; Cameron, B.; Laxer, R.; et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: Results of a randomized controlled pilot trial. Arthritis Rheum. (Arthritis Care Res.) 2008, 59, 1399–1406. [Google Scholar] [CrossRef] [PubMed]
- Creamer, P.; Singh, B.B.; Hochberg, M.C.; Berman, B.M. Sustained improvement produced by nonpharmacological intervention in fibromyalgia: Results of a pilot study. Arthritis Care Res. 2000, 13, 198–204. [Google Scholar] [CrossRef]
- Lynch, M.E.; Sawynok, J.; Bouchard, A. A pilot trial of CFQ for treatment of fibromyalgia. J. Altern. Complement. Med. 2009, 15, 1057–1058. [Google Scholar] [CrossRef] [PubMed]
- Sawynok, J.; Lynch, M.; Marcon, D. Extension trial of qigong for fibromyalgia: A quantitative and qualitative study. Evid. Based Complement. Altern. Med. 2013. [Google Scholar] [CrossRef] [PubMed]
- Sawynok, J.; Hiew, C.; Marcon, D. Chaoyi Fanhuan Qigong and fibromyalgia: Methodological issues and two case reports. J. Altern. Complement. Med. 2013, 19, 383–386. [Google Scholar] [CrossRef] [PubMed]
- Sawynok, J.; Lynch, M. Qualitative analysis of a controlled trial of qigong for fibromyalgia: Advancing understanding of an emerging health practice. J. Altern. Complement. Med. 2014, 20, 606–617. [Google Scholar] [CrossRef] [PubMed]
- Sawynok, J. Qigong and chronic pain: Three cases of pain resolution, other health benefits and improved vision with long-term practice of qigong. Fibromyalgia Open Access 2016. [Google Scholar] [CrossRef]
- Chan, J.S.M.; Ho, R.T.H.; Chung, K.F.; Wang, C.W.; Yao, T.J.; Ng, S.M.; Chan, C.L.W. Qigong exercise alleviates fatigue, anxiety, and depressive symptoms, improves sleep quality, and shortens sleep latency in persons with chronic fatigue syndrome-like illness. Evid. Based Complement. Altern. Med. 2014. [Google Scholar] [CrossRef] [PubMed]
- Boutron, I.; Moher, D.; Altman, D.G.; Schulz, K.F.; Ravaud, P. Extending the CONSORT statement to randomized trials of nonpharmacological treatment: Explanation and elaboration. Ann. Intern. Med. 2008, 148, 295–309. [Google Scholar] [CrossRef] [PubMed]
- Rowbotham, M.C.; Gilron, I.; Glazer, C.; Rice, A.S.C.; Smith, B.H.; Stewart, W.F.; Wasan, A.D. Can pragmatic trials help us better understand chronic pain and improve treatment? Pain 2013, 154, 643–646. [Google Scholar] [CrossRef] [PubMed]
- Arnold, L.M.; Clauw, D.L.; Dunegan, L.J.; Turk, D.C. A framework for fibromyalgia management for primary care providers. Mayo Clin. Proc. 2012, 87, 488–496. [Google Scholar] [CrossRef] [PubMed]
- Briones-Vozmediano, E.; Vices-Cases, C.; Ronda-Pérez, E.; Gil-González, D. Patients’ and professionals’ views on managing fibromyalgia. Pain Res. Manag. 2012, 18, 19–24. [Google Scholar] [CrossRef]
- Cassisi, G.; Ceccherelli, F.; Atzeni, F.; Sarzi-Puttini, P. Complementary and alternative medicine for fibromyalgia: A practical clinical debate of agreements and contrasts. Clin. Exp. Rheumatol. 2013, 31 (Suppl. 79), S134–S152. [Google Scholar] [PubMed]
- Saad, M.; de Medeeiros, R. Complementary therapies for fibromyalgia syndrome—A rational approach. Curr. Pain Headache Rep. 2013. [Google Scholar] [CrossRef] [PubMed]
Characterization of Qigong | Reference | Comments, Conclusions |
---|---|---|
(1) Meditative Movement for FM (systematic review, meta-analysis) | Langhorst et al., 2013 [12] | Did not include any 2012 qigong RCTs; effect sizes in medium range; concluded high quality trials needed |
(2) Qigong for FM (systematic review, meta-analysis) | Lauche et al., 2013 [13] | Considered N = 6 RCTs of qigong for FM; concluded qigong may be useful, but recommendation regarded as weak based on trial quality |
(3) Complementary and Alternative Exercise for FM (meta-analysis) | Mist et al., 2013 [14] | Noted medium-to-large effect sizes; concluded little risk in recommending as component of multimodal treatment |
(4) Qigong for FM (review) | Sawynok, Lynch 2014 [15] | RCTs involving daily practice for 6–8 weeks show consistent medium-to-large effect sizes in core domains, with benefits sustained at 4–6 months; concluded qigong merits continued exploration for FM |
(5) Mind–body therapies for FM (as part of rheumatic diseases) (review) | Del Rosso, Maddali 2016 [16] | Notes variable results in 4 RCTs in FM (one in children); did not cite 2 adult RCTs from 2012; concluded mind–body therapies useful for overall health in rheumatic diseases |
Study Characteristics | Outcomes, Features |
---|---|
(1) Astin et al., 2003 [17] N = 128; N = 64 qigong, N = 64 education support Means: age 47.7 yrs, FM duration 5.0 yrs Intervention: Qigong (Dance of Phoenix) + mindfulness meditation, 2.5 h weekly group session for 8 wks (no mention of home practice) Attrition: 39% 8 wks, 48% 4 mos, 67% 6 mos | Outcomes: B, 8 wks, 4 mos, 6 mos (1) Between-group NS for FIQ, pain, depression (2) Within-group comparisons show significant improvements in all measures, maintained at follow-up (3) First controlled study of qigong for FM (4) Confounded by multiple interventions |
(2) Mannerkorpi, Arndow 2004 [18] N = 38; N = 19 qigong, N = 19 normal activities Means: age 45 yrs, FM duration 10 yrs Intervention: qigong (style not reported) + body awareness; 1.5 h weekly group sessions for 3 mos (encouraged to practice at home, but none did) Attrition: 14 (39%) | Outcomes: B, 3 mos (1) Within-group body awareness changes in treatment, but not control group; within-group FIQ improvement in control but not intervention group; all other measures NS (2) Confounded by multiple interventions |
(3) Haak, Scott (2008) [19] N = 57; N = 29 qigong, N = 28 wait-list Means: age 53.3 yrs, FM duration 15.4 yrs Intervention: qigong (He Hua), 11.5 h instruction/practice over 7 wks (encouraged to practice 2 × 20 min/day; 2 external qigong sessions) Attrition: 1 (2%) Note: At end of wait-list, subjects also received qigong training; allows for individual and combination group analysis | Outcomes: B, 8 wks, 4 mos (1) Between-group pain, sleep, psychological function all significantly improved at 8 wks, 4 mos (2) Many effect sizes medium-to-large (3) Good reproducibility between immediate and delayed intervention groups (4) Combination qigong group data (N = 56) shows benefits in all domains following intervention; these are maintained at follow-up |
(4) Liu et al., 2012 [20] N = 14; N = 8 qigong, N = 6 sham exercise Means: age 56.6 yrs, FM duration 9.4 yrs Intervention: qigong (Liu Zi Jue, 6 Healing Sounds), 2 training sessions, 1 hr weekly group sessions, daily home practice (2 × 15–20 min) for 6 wks; sham had movement but no meditation or sound Attrition: 2/8 in intervention group Note: (1) Only study to use sham exercise. (2) Participants recorded practice time, with moderate-to-high compliance (75–85%) | Outcomes: B, 6 wks (1) Significant within-group effects for pain, fatigue, sleep, FIQ in qigong but not in sham group (2) Between-group effect sizes calculated in the report were large (1–2) in all domains (3) Trial is limited by small numbers |
(5) Lynch et al., 2012 [21] N = 100; N = 53 qigong, N = 47 wait-list Means: age 52 yrs, FM duration 9.6 yrs Intervention: qigong (Chaoyi Fanhuan), 3 half-day training sessions, 45 min daily home practice over 8 weeks (home practice reported) Attrition: 12% at 6 mos; 29% at 12 mos Note: (1) At end of wait-list, subjects also received qigong training; allows for individual and combination group analysis. (2) Largest qigong study in FM to date. (3) Study design allowed for two cohorts to be analysed. (4) Numbers allowed for analysis of practice-response relationship | Outcomes: B, 8wks, 4 mos, 6 mos (1) Significant between-group effects for pain, sleep, FIQ, physical and mental function (2) Similar beneficial effects in all domains in the immediate and delayed intervention groups (3) Combination qigong group (N = 73) showed many medium-large effect sizes [15] (4) N = 38 (52%) per protocol (≥5 h/wk); effect sizes in this group uniformly high (0.95–1.67) [15] (5) Comparison of N = 38 with those who practiced minimally (≤3 h/wk) showed significant differences in outcomes in all domains |
(6) Maddali Bongi et al., 2012 [22] N = 30; N = 15 qigong, N = 15 Rességuier method Means: age 57.3 yrs, FM duration 7.2 yrs Intervention: qigong style not clear; 2 × 45–60 min sessions wks 1–3, one session for wks 4–7; 7 wks; daily home exercise for 30 min during intervention Attrition: 0% when training commenced, but 8/38 withdrew following randomization Note: (1) Cross-over trial; after first 7 weeks, 1 wk break, then 7 weeks of other method. (2) Comparative trial between two mind–body practices. (3) Initial 7 weeks is comparison trial; remainder considered an add-on trial | Outcomes: B, 7 wks, 15 wks, 6 mos (1) Significant improvements in pain, sleep, FIQ, and mental function in both groups (within-group comparisons) over initial 7 wks (2) No additional improvements at the end of 15 wks following addition of the other method (3) Effects in all domains maintained at 6 mos (4) Effect sizes generally range from 0.7 to 1.5 in both groups [15] |
Study Characteristics | Outcomes, Features |
---|---|
(1) Creamer et al., 2000 [25] Pilot study, open label; N = 28 Means: age 47.9 yrs, FM duration not reported Intervention: 8 × 2.5 h weekly sessions involving education, cognitive/behavioural components (30 min) relaxation/meditation (60 min), qigong (60 min, form not specified), for 8 wks Attrition: 8/28 (29%) did not complete 5/8 sessions | B, 8 wks, 4 mos, 6 mos (1) Significant improvements in FIQ, sleep, pain, and other forms of function after program; benefits generally maintained at 4 and 6 mos (2) Intent-to-treat analysis of results Limitations: high attrition; multiple techniques used as intervention, so not possible to ascribe effects to any particular one |
(2) Chen et al., 2006 [23] Pilot study, open label; N = 13 Means: age 49.8 yrs, FM duration 6.2 years Intervention: external qigong applied for 5–7 × 45 min sessions over 3 weeks; monthly maintenance session during follow-ups to 3 mos Attrition: 3/13 (23%) dropped out after 1–3 sessions, data for N = 10 analysed | B, 3 wks, 1 mo, 3 mo (1) Within-group significant improvements in FIQ, pain, depression, anxiety, but not sleep, following qigong (2) Benefits generally maintained at 1 and 3 mos, although there was some rebound (3) Within-subject effect sizes 0.7–1.9 [15] (4) Two cases had such dramatic and persistent benefit following treatment that they considered themselves cured; individual outcomes indicate minimal residual symptomology Limitations: low numbers; dropouts; unclear justification for protocol used; unclear mechanism of external qigong |
(3) Lynch et al., 2009 [26] Pilot study, open label; N = 23 Means: age 51.5 yrs, FM duration 12.0 yrs Intervention: Two 4 h training sessions (level 1 CFQ), weekly 1.5 h practice/review sessions; 9 wks (daily home practice 45 min recommended, but not monitored) Attrition: 21 (91%) completed 4 wks, 14 (61%) completed 9 wks, 13 (52%) completed follow-up | B, 9 wks, 3 mos, 6 mos (1) Within-group significant improvements in pain, FIQ and physical function following intervention, and at follow up (effect sizes 0.6–0.9) [15] (2) Analysis conducted on N = 12 (52%) who completed the trial Limitations: dropouts; unclear justification for protocol used |
(4) Sawynok et al., 2013 [27] Extension trial to RCT [21], N = 20 Intervention: Level 2 CFQ instruction over 2 × 4 h, and 45 min daily practice (levels 1/2) for a further 6 mos Attrition: 7/20 (35%) Note: (1) Total qigong practice time is at least 12 months, but not necessarily consecutive; 5/13 who completed the extension had continued on with community-based practice following the RCT. (2) Both quantitative and qualitative outcomes, as well as practice times, recorded | Quantitative: For N = 13 who completed extension, significant within-group improvements in pain, FIQ, sleep and function; 5/13 had voluntarily continued with community practice following the RCT and reported practicing 10–15 h/wk Qualitative: Comments recapitulated benefits in qualitative domains; also noted benefits in food allergies, chemical sensitivities, asthma, migraines, blood pressure, vision; several medications discontinued Limitations: low numbers; dropouts; retrospective selection |
(5) Sawynok et al., 2013 [28] Case reports, N = 2 females (45, 57 yrs) with FM (10, 20 yrs) who undertook community-based qigong (level 1, level 2 CFQ) at workshops and practiced ≥1 h/day for 6 mos; practice levels up to 1.5–3 h/day following repeat workshops; 3 yrs qigong experience Note: (1) Both had previously tried many other therapies, both conventional and complementary, but remained symptomatic. (2) Both undertook continued qigong training and practice because of health experiences with initial practice (over months) | Case 1: initial improvements in pain, tension, anxiety, food sensitivities, blood pressure; 12 mos: medications and supplements discontinued; 3 yrs: minimal pain (occasional, local), headaches gone, cognition, sleep, fatigue, mood, skin and circulation all improved Case 2: initial improvements in energy and bowel and bladder function; 6–12 mos: vast improvement in pain and other symptoms (including vision); 3 yrs: resumed eating foods previously allergic to, stopped amitriptyline and supplements Limitations: unknown generalizability; retrospective selection |
(6) Sawynok and Lynch 2014 [29] Retrospective analysis of qualitative comments by N = 73 who completed initial 6 mo RCT [21] Note: (1) Given that benefits were shown to be related to amount of practice [21], narrative comments for extension trial completers were considered separately in a post hoc manner. (2) Comments for those who practiced per protocol (≥5 h/wk; N = 38), minimally (≤3 h/wk; N = 13), or in between considered as blocks | Narrative: There was a difference in initial experiences (over 6 mos) with qigong by those who completed the extension trial (N = 13) vs. those who did not complete (N = 7); comments recapitulate quantitative domain measures, but also cover other areas Thematic: There was a clear difference in comments on pain, sleep and quality of life by those who practiced per protocol compared to those who practiced minimally; the intermediate group also made positive comments, but these were more moderate in tone Limitations: variable depth of qualitative comments offered by different participants |
(7) Sawynok 2016 [30] Case reports (37, 57 and 57 yrs old) of females with fibromyalgia/chronic pain (also other symptoms) of 12–20 yrs duration who undertook extensive qigong practice over 8–15 yrs, practicing 1–3 h/day at times Note: (1) All three experienced improvements in their vision, and the selection of cases was based on this. (2) It would be impossible to conduct a prospective trial involving these amounts of practice over these intervals | Case 1: Commenced qigong in 2008; had FM with multiple issues, all of which resolved over time; currently takes no medications; improvements in vision occured gradually over time (acuity changes 1.5–1.75) Case 2: Commenced qigong in 2006; had FM, arthritis, back pain, sleep apnea, high cholesterol, allergies/food intolerances, irritable bowel syndrome, frequent bouts of pneumonia/infections. Practiced qigong extensively; health improvements in pain and other areas occurred gradually and with different time courses. Currently pain free with improvement in all health areas. Vision changes reflect genetics and surgery. Case 3: Commenced qigong in 2000; multiple health conditions (pain, headaches, sleep disturbance, irritable bowels, food allergies); all health areas improved. Visual acuity improved 2.0 units over first decade of practice in one eye (blind in other eye since birth). Limitations: unknown generalizability; retrospective selection |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sawynok, J.; Lynch, M.E. Qigong and Fibromyalgia circa 2017. Medicines 2017, 4, 37. https://doi.org/10.3390/medicines4020037
Sawynok J, Lynch ME. Qigong and Fibromyalgia circa 2017. Medicines. 2017; 4(2):37. https://doi.org/10.3390/medicines4020037
Chicago/Turabian StyleSawynok, Jana, and Mary E. Lynch. 2017. "Qigong and Fibromyalgia circa 2017" Medicines 4, no. 2: 37. https://doi.org/10.3390/medicines4020037
APA StyleSawynok, J., & Lynch, M. E. (2017). Qigong and Fibromyalgia circa 2017. Medicines, 4(2), 37. https://doi.org/10.3390/medicines4020037